Form 4: Centessa Pharmaceuticals General Counsel Sells Shares Under 10b5-1 Plan

Iqbal J Hussain, General Counsel of Centessa Pharmaceuticals, sold 6,000 ordinary shares at an average price of $15.29, according to a Form 4 filing.

Summary

• Iqbal J Hussain, the General Counsel of Centessa Pharmaceuticals plc, reported a transaction involving the company's ordinary shares on January 15, 2025.
• Hussain exercised options to acquire 6,000 shares at a price of $5.84.
• Simultaneously, Hussain sold 6,000 shares at a weighted average price of $15.29, with individual sales ranging from $15.09 to $15.43.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 14, 2024.
• Following these transactions, Hussain directly owns 118,265 ordinary shares and indirectly owns 5,500 shares through a spouse.
• Hussain also holds options to purchase 321,559 ordinary shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects a routine transaction under a pre-existing trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding transactions by company insiders. These filings are closely watched by investors to gauge management's sentiment and potential future performance.

Stakeholder Impact

• The sale of shares by a company insider may be perceived differently by stakeholders.
• Some may view it as a lack of confidence, while others may recognize it as part of a pre-planned diversification strategy.

Key Dates